3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonyl chloride, 95.0%, 1g

(R)-3-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid, 95.0%, 50mg

2-(1-(TERT-BUTOXYCARBONYL)-3-METHYLAZETIDIN-3-YL)ACETIC ACID, 95.0%, 500mg

2,2,2-Trifluoroethanol, min. 99.8%, for synthesis, 100 ml, glass packaging

N-(2-((2-Oxoazepan-3-yl)carbamoyl)phenyl)benzo[b]thiophene-2-carboxamide, 98%, 10mg

2-Phenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)5g

3-Bromo-9-(p-tolyl)-9H-carbazole, 97%, 250mg

1-(Quinoxalin-2-yl)ethanone, 97.0%, 5g

ethyl 4-(4-chlorophenoxy)-3-oxobutanoate, 95.0%, 5g

3-Aminopropionitrile Fumarate>98.0%(T)500g

Isopropyl-(1-methyl-piperidin-4-yl)-amine, 95.0%, 250mg

(R)-3-Cyclohexyl-2-methylpropanoic acid, 95%, 1g

2-Bromobenzaldehyde, 98.0%, 25g